To further analyze the enhancement of EPO on the effects of stem cell-based therapy, Eliopoulos et al. reported that BMSCs, which were genetically enhanced to secrete EPO, could produce significant beneficial effects in AKI therapy [26]. Here, EPO is linked to acute kidney injury.